<DOC>
	<DOCNO>NCT01933698</DOCNO>
	<brief_summary>The aim present study compare pharmacokinetic profile evaluate bioequivalence two commercial amoxicillin-suspension formulation healthy Brazilian volunteer .</brief_summary>
	<brief_title>Bioequivalence Two Commercial Amoxicillin Suspensions</brief_title>
	<detailed_description>Under fast condition , 25 volunteer ( 13 male 12 female ) include randomize , open-label , two-period crossover ( 1-week washout interval ) bioequivalence study . Blood sample collect pre-dose ( 0h ) 0.5 , 1 , 1.33 , 1.66 , 2 , 2.5 , 3 , 4 , 6 , 8 12 hour drug ingestion . Pharmacokinetic parameter ( Cmax , Tmax , T1/2 , Area-under-curve0-12h Area-under-curve0-inf ) calculate plasma concentration formulation subject .</detailed_description>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>negative HIV , hepatitis B virus , hepatitis C virus , addictive drug pregnancy test woman age 19 46 year weight 52 85 kg body mass index 17.6 28.4kg/m2 ability provide write consent laboratory exam result within normal range healthy individual and/or medically acceptable defined clinical investigator ; feed habit consistent standardization study pregnancy history hypersensitivity penicillin ( normal idiosyncratic drug reaction ) evidence dysfunction clinically significant deviation normal history psychiatric illness might compromise ability provide write consent history gastrointestinal disease , hepatic , renal , pulmonary , cardiovascular , hematological , neurological diabetes glaucoma active smoker consumption 5 cup coffee tea per day history drug dependence abuse alcohol consumption use enzymaticinducers drug within 30 day systemic medication ( include prescription drug , painkiller , hepatoprotective , influenza , etc ) within 14 day start study participation clinical study 9 week prior study lose donate 350 mL blood last three month subject abnormal diet reason ( therapeutic , aesthetic , religious , etc . ) adequate venous access .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>46 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Amoxicillin</keyword>
	<keyword>Human</keyword>
</DOC>